IL1B and Parkinson disease: Fan et al. [33] further demonstrated that plasmaIL-1β levels were significantly higher in PD patients and were positivelycorrelated with Hoehn-Yahr (H-Y) stage and Unified Parkinson’s Disease RatingScale (UPDRS) Part III scores, suggesting that IL-1β could serve as anon-invasive marker for assessing disease severity.